These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reconstruction of N-acetyltransferase 2 haplotypes using PHASE. Golka K; Blaszkewicz M; Samimi M; Bolt HM; Selinski S Arch Toxicol; 2008 Apr; 82(4):265-70. PubMed ID: 17879084 [TBL] [Abstract][Full Text] [Related]
3. Clarifying haplotype ambiguity of NAT2 in multi-national cohorts. Selinski S; Blaszkewicz M; Agundez JA; Martinez C; Garcia-Martin E; Hengstler JG; Golka K Front Biosci (Schol Ed); 2013 Jan; 5(2):672-84. PubMed ID: 23277078 [TBL] [Abstract][Full Text] [Related]
4. Algorithm for the Automated Evaluation of NAT2 Genotypes. Michael G; Thier R; Blaszkewicz M; Selinski S; Golka K Methods Mol Biol; 2018; 1655():77-96. PubMed ID: 28889379 [TBL] [Abstract][Full Text] [Related]
5. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population. Zahra MA; Kandeel M; Aldossary SA; Al-Taher A Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768 [TBL] [Abstract][Full Text] [Related]
8. An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians. Balaji L; Krishna BS; Bhaskar LV Arch Oral Biol; 2012 May; 57(5):513-8. PubMed ID: 22137356 [TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups. Suarez-Kurtz G; Fuchshuber-Moraes M; Struchiner CJ; Parra EJ Pharmacogenet Genomics; 2016 Aug; 26(8):363-9. PubMed ID: 27136043 [TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. García-Closas M; Hein DW; Silverman D; Malats N; Yeager M; Jacobs K; Doll MA; Figueroa JD; Baris D; Schwenn M; Kogevinas M; Johnson A; Chatterjee N; Moore LE; Moeller T; Real FX; Chanock S; Rothman N Pharmacogenet Genomics; 2011 Apr; 21(4):231-6. PubMed ID: 20739907 [TBL] [Abstract][Full Text] [Related]
11. Association between NAT2 polymorphisms and the risk of schizophrenia in a Northern Chinese Han population. Luan Z; Lu T; Yue W; Copray S; Zhang D Psychiatr Genet; 2017 Apr; 27(2):71-75. PubMed ID: 28187106 [TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia. Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782 [TBL] [Abstract][Full Text] [Related]
13. NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization. Herrera-Rodulfo A; Carrillo-Tripp M; Laura Yeverino-Gutierrez M; Peñuelas-Urquides K; Adiene González-Escalante L; Bermúdez de León M; Silva-Ramirez B Clin Chim Acta; 2021 Aug; 519():153-162. PubMed ID: 33932406 [TBL] [Abstract][Full Text] [Related]
14. Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Jiao L; Doll MA; Hein DW; Bondy ML; Hassan MM; Hixson JE; Abbruzzese JL; Li D Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2379-86. PubMed ID: 18006927 [TBL] [Abstract][Full Text] [Related]
15. NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis. Higuchi N; Tahara N; Yanagihara K; Fukushima K; Suyama N; Inoue Y; Miyazaki Y; Kobayashi T; Yoshiura K; Niikawa N; Wen CY; Isomoto H; Shikuwa S; Omagari K; Mizuta Y; Kohno S; Tsukamoto K World J Gastroenterol; 2007 Dec; 13(45):6003-8. PubMed ID: 18023090 [TBL] [Abstract][Full Text] [Related]
16. Inferring haplotypes at the NAT2 locus: the computational approach. Sabbagh A; Darlu P BMC Genet; 2005 Jun; 6():30. PubMed ID: 15932650 [TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase polymorphism among northern Sudanese. Al-Yahyaee S; Gaffar U; Al-Ameri MM; Qureshi M; Zadjali F; Ali BH; Bayoumi R Hum Biol; 2007 Aug; 79(4):445-52. PubMed ID: 18075007 [TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A. Dandara C; Masimirembwa CM; Magimba A; Kaaya S; Sayi J; Sommers DK; Snyman JR; Hasler JA Pharmacogenetics; 2003 Jan; 13(1):55-8. PubMed ID: 12544513 [TBL] [Abstract][Full Text] [Related]
19. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937 [TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population. Chelouti H; Khelil M Ann Hum Biol; 2017 Sep; 44(6):531-536. PubMed ID: 28347189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]